Pentorex, also known as phenpentermine or α,β-dimethylamphetamine and sold under the brand name Modatrop, is a stimulant drug of the amphetamine family related to phentermine (α-methylamphetamine) which is used as an anorectic to assist with weight loss.[1][2] It also acts as a diuretic.[3] Pentorex was developed by Nordmark in the 1960s.[4]

It is a derivative of 2-phenyl-3-aminobutane (β-methylamphetamine).

See also

References

  1. ^ Behrendt WA, Deininger R (August 1963). "On the Pharmacology of 2-Phenyl-3-Methyl-3-Butylamine, A Substance with Anorexic Action". Arzneimittel-Forschung (in German). 13 (8): 711–6. PMID 14090434.
  2. ^ Opitz K, Kemper F, Loeser A (March 1965). "[Comparative study of the anorexigenic potency of some appetite depressants]". Arzneimittel-Forschung (in German). 15 (3): 278–81. PMID 5897218.
  3. ^ Opitz K (February 1965). "Natriuretisch-diuretische Wirkung von appetithemmenden Amphetamin-Derivaten". Klinische Wochenschrift (in German). 43 (4): 225–7. doi:10.1007/BF02350860. PMID 14265209. S2CID 46237660.
  4. ^ GB patent 995063, "A Substituted Butylamine and Salts thereof", issued 1965-06-10, assigned to Nordmark 
Allikas: https://en.wikipedia.org/wiki/Pentorex
No tags for this post.